3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
5
Thoracic
2
Gastrointestinal
2
Head & Neck
1
Gynecologic
1
Dermatologic
1
Breast
1
Conditions
Melanoma
49
Carcinoma, Basal Cell
12
Neoplasm Metastasis
9
Lymphoma, T-Cell, Cutaneous
9
Skin Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Lymphoma, T-Cell
5
Colorectal Neoplasms
5
Carcinoma, Merkel Cell
5
Uveal Melanoma
4
Uterine Cervical Neoplasms
4
Mycosis Fungoides
4
Lymphoma
4
Lung Neoplasms
4
Carcinoma, Renal Cell
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Follicular
3
Keratosis, Actinic
3
Endometrial Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Sezary Syndrome
2
Prostatic Neoplasms
2
Interventions
aldesleukin
15
pembrolizumab
11
Cyclophosphamide
9
fludarabine phosphate
7
fludarabine
6
Nivolumab
6
Interleukin-2
6
atezolizumab
5
Radiotherapy
5
Ipilimumab
4
Interferon-alpha
4
Drug Therapy
4
Blood Specimen Collection
4
Radiosurgery
3
tremelimumab
2
temsirolimus
2
durvalumab
2
cemiplimab
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Paclitaxel
2
Metformin
2
Interleukin-12 Subunit p35
2
Genistein
2
Gene Expression Profiling
2
Flow Cytometry
2
Filgrastim
2
Cetuximab
2
zanolimumab
1
vivitrol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Biopsy
×
Dermatologic
×
Clear all
NCT07327489
2026-01-08
ELEPHAS-05
Elephas
Recruiting
2,000 enrolled